Between 2011–12 and 2023–24, average protein consumption rose marginally by 1–3 grams across rural and urban households. In ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...

Danish pharmaceutical company Novo Nordisk on Tuesday launched its once-weekly injectable weight-loss drug Wegovy in India, at Rs 4,336.25 per dose. Wegovy, a once-weekly glucagon-like peptide-1 ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Over the past two decades, India has seen a sharp rise in obesity among women, particularly in urban areas. According to the National Family Health Survey (NFHS-5), nearly 24% of Indian women aged ...

Study highlights rising obesity rates among Indian women, urging urgent public health action to address fertility and long-term health risks. Nearly half of Indian women aged 35–49 are ...

Causes of Abdominal Obesity. One of the biological drivers of this crisis lies in how South Asians, including Indians, store fat. Research shows that compared to white Caucasians with the same ...